Getting the Deal Through: Navigating Antitrust Scrutiny of Health System Deals and Beyond

Overview


According to a new report by the Health Care Cost Institute, nearly three-quarters of 112 metropolitan areas across 43 states have “highly concentrated” hospital markets—showing a rise of such areas from 67% in 2012 to 72% in 2016. And in today’s regulatory environment, this trend shows no sign of deceleration as health systems grapple with reimbursement, cost and other mission critical pressures.

This M&A activity is set against a backdrop of intensive antitrust scrutiny. The Federal Trade Commission (FTC) and often state attorneys general reviews can be challenging from a time and resource perspective. Join McDermott’s healthcare antitrust team for a webinar in which they’ll discuss and offer insight on what health systems and other industry participants can do to best position their deal for review. Topics include first-hand observations on various government practices, including:

  • Greater willingness to investigate discrete individual overlapping service lines and increasingly narrow geographic areas;
  • Growing reliance on econometric tools and economic analysis in their reviews;
  • Analytical approach toward markets where narrow and tiered networks are on the rise; and
  • Assessment of how local ACOs or CINs may factor into competitive effects analysis of a health system merger.

Time
12:00 – 1:00 pm ET

Webinar

Dig Deeper

Düsseldorf, Germany / McDermott Event / November 20, 2019

US Market Entry Forum and Networking Reception During MEDICA

Webinar / McDermott Event / November and December 2019

Regulatory Sprint to Coordinate Care Webinars

Düsseldorf, Germany / Speaking Engagements / November 18 - 21, 2019

MEDICA and DxPx

Webinar / Speaking Engagements / November 12, 2019

Navigating Antitrust Scruntiny of Health Systems and Beyond

Webinar / McDermott Event / November 7, 2019

Critical Developments in Healthcare Cybersecurity